Contraceptives

Published by: Global Industry Analysts

Published: Mar. 1, 2008 - 503 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Oral Contraceptives

Condoms

Implants/Injections

Other Contraceptives

II. EXECUTIVE SUMMARY

1. Outlook

Table 1: Global Contraceptive Market (2004): Percentage Market Share Breakdown of Leading Players - Schering AG, Johnson & Johnson, Barr Pharmaceuticals, Akzo Nobel, Watson Labs, Wyeth Laboratories, and Others (includes corresponding Graph/Chart)

Multifunctional Modern Contraceptives Make a Foray

Top 5 Brands in the World Hormonal Contraceptives Market As of the Year 2005

Extensive Distribution Drives growth of Contraceptive Products

Advertising for Contraceptives Acquires A Whole New Dimension

Manufacturers & Retailers Work in Sync to Accelerate Sales

Innovation Keeps the Fire Burning for the Condoms Market

Hormonal Contraceptives - Select Trends

Table 2: Global Female Contraception Market (2004): Percentage Share Breakdown of Select Geographic Markets - United States, Europe, Latin America/ Canada, Japan, and Rest of World (includes corresponding Graph/Chart)

Generic & Biosimilar Contraceptive Products Gain Ground

Generics Manufacturers

Key Players in the Generic Hormonal Contraceptives Market

Select Players in the Branded Biosimilar Hormonal Contraceptives Market in Developing Countries

OTC Hormonal Contraceptives - An Attractive Market

R&D Companies & Generic Manufacturers - Developing Countries

Commercial Success of R&D Brands Sustain Developmental Programs in Developing Countries

Challenges Facing Generic Contraceptive Products Manufacturers

2. Product Overview and Analysis

Types of Contraception

The Contraceptive Timeline

Table 3: World Contraceptive Prevalence (2005): Percentage Use of Select Contraception Methods In Less Developed and Developed Regions - Traditional Method, Pill, IUD, Condom, Implant/Injectables, Male Sterilization, Female Sterilization (includes corresponding Graph/Chart)

Classification

By Function

Barrier Contraceptives

Characteristic Features of Barrier Methods

Hormonal Contraceptives

Prescription Contraceptives

Oral Contraceptives

Overview of Oral Contraceptives - Benefits Vs. Risks

Usage Levels of OCs in Worldwide Scenario

Table 4: Percentage of Women in the age group 15-49 using contraception across select regions and countries for the years 2005 and 2006

Traditional and Modern

Reversible and Permanent

Table 5: Birth Control Methods and their Use in Major Regions Worldwide

Contraception - Levels of Effectiveness

Table 6: Effectiveness Index of Contraceptive Measures

Unmet Need for Contraception

Table 7: Worldwide Contraceptives Market: Percentage Share of Unmet Needs (Recent Past Data for 2003) - for Kenya, NE Brazil, Pakistan, Senegal, Turkey, Colombia, Nigeria, Egypt, Indonesia and Morocco (includes corresponding Graph/Chart)

Segmental Analysis

A. Condoms

Overview

Categories

Latex Condoms

Non-Latex Condoms

Skin Condoms

Polyurethane (PU) Condoms

Table 8: Leading Product Types in the US Condoms Market (2005) -Percentage Share Breakdown for Latex, Synthetic/Polyurethane and Natural (includes corresponding Graph/Chart)

Comparison Between Polyurethane & Latex Condoms

Male Condom - Effectiveness of Protection Against STDs

Myths & Facts

Selection & Effective Use of Condoms

Condoms in the War Against AIDS

Highlights

Growth Factors

Factors Hindering Wide Spread Use of Condoms

Measures Aimed at Increasing Usage

Female Condoms

Who are the Main Users?

Reality - An Effective Female Condom

Market Shares: Year 2002 & 2003

Table 9: Worldwide Condoms Market: Leading Players (Recent Past Data for 2002 & 2003) - Percentage Share Breakdown by Value Sales - SSL, Ansell, Church & Dwight, Okamoto, and Others (includes corresponding Graph/Chart)

B. Oral Contraceptives (OCs)/Pills

A Peep into the Past

Synthetic Oral Contraceptives

Characteristic Features of Oral Contraceptives (OCs)

Top Brands/Manufacturers of Oral Contraceptive Formulations Containing Levonorgestrel 0.15 MG/ Ethinyl Estradiol 30 mcg

Table 10: Leading Methods of Contraception Worldwide - Female sterilization, Intrauterine devices, Oral contraceptives, Condom, Male Sterilization, Injectable contraceptives, and Others (includes corresponding Graph/Chart)

Bayer Schering Pharma’s “Yasmin”: A Resounding Brand Worldwide

Table 11: Sales of Bayer Schering Pharma AG's Yasmin, and Yaz for the Years 2007 and 2009 (In Euro Millions)

Advantages of Using OCs

Table 12: Leading Methods of Contraception Worldwide - Female sterilization, Intrauterine devices, Oral contraceptives, Condom, Male Sterilization, Injectable contraceptives, and Others (includes corresponding Graph/Chart)

Effects of Long-Term Use of Ocs

Use of OCs/Pills - Myths & Facts

Oral Contraceptives - Challenges & Strategies to Overcome Problems

Factors Associated with Failure of OCs/Pills

Health Conditions to be Addressed when Using OCs

Understanding Risks Associated with Use of OCs

Cardiovascular Disease - A Major Side Effect of OC

Intake of OCs Result in High Blood Pressure

Smoking Intensifies Respiratory Problems in Pill Users

Complications Arising by Use of OCs Directly Related to Age

Relation Between the OC and Cancer

Depression Linked to Use of OCs

OCs Increases Osteoporosis Risk at Later Stage

OCs May Reduce Sex Drive

Effects of Pill on Childbearing Capacity

Visiting a Doctor - Highly Recommended in Case of Warning Symptoms

Emergency Contraception (EC) - A New Face of Ocs

Role of ECPs

Effectiveness of ECP

Different Types of EC Products

Mini Pills

RU486 - the French Abortion Pill

Top Brands/Manufacturers of Emergency Contraceptive Pills Containing Levonorgestrel 0.75 mg

Top Brands/Manufacturers of Emergency Contraceptive Pills Containing Levonorgestrel 10.25mg and Ethinyl Estradiol 50mcg

Availability of Hormonal Contraceptives as OTC Drugs

C. Injectable Contraceptives

Depo-Provera

Characteristic Features of Injectable Contraceptives

Injectables - Challenges & Strategies to Overcome Problems

Top Brands & Manufacturers of Two & Three Month Injectable Contraceptive Formulations Containing Depot Medroxyprogesterone Acetate (DMPA), and Norethisterone Enanthate

Top Brands & Manufacturers of Monthly Injectable Contraceptive Formulations Containing (Norethisterone Enanthate 50 mg and Estradiol Valerate 5 mg), (Dihydroxy Progesterone Acetophenide 75 mg and Estradiol Enanthate 5 mg), (Medroxyprogesterone Acetate 25 mg and Estradiol Cypionate 5 mg), (Algeston acetophenide 150 mg and Estradiol Enanthate 10 mg), and Hydroxiprogesterone Caproate 250 mg

D. Intrauterine Devices (IUDs)/Implants

Product Categories

CopperT 380A (ParaGard)

Progesterone T (or Progestasert)

Characteristic Features

Benefits

Side Effects

Challenges & Strategies to Overcome Problems

Table 13: IUD Users Worldwide (2005): Percentage Breakdown by Select Geographic Country/Region (includes corresponding Graph/Chart)

Long-term Reversible Contraceptive Implants

Products

Norplant

Implanon

Mirena

Characteristic Features of Implantable Contraceptives

Challenges & Strategies to Overcome Problems

E. Spermicides

Product Categories

Benefits

Drawbacks

Contraceptive Foam

Delfen Contraceptive Foam

Contraceptive Cream or Jelly

Encare Ovals

F. Diaphragms

G. Withdrawal & Douching

H. Sterilization

Tubal Ligation

Reasons Behind Adoption

Risk of Complications

Types

Abdominal Procedures

Laparoscopy

Mini-Laparotomy

Laparotomy

Vaginal Procedures

Culdoscopy

Colpotomy

Hysterectomy - A High Risk Surgery

Selective Tubal Occlusion Procedure (STOP)

Vasectomy

Method of Working

Reasons Behind Adoption

Risk of Complications

I. Other Contraceptive Methods

Contraceptive Sponges

Today Sponge

Characteristic Features of Today Sponge

Table 14: Efficiency Rates of Today Sponge Based on Usage for 12-Month Period (includes corresponding Graph/Chart)

Allendale Pharmaceuticals

Protectaid Sponge

Characteristic Features of Protectaid Sponge

Cervical Caps

Pros and Cons of the Device

Vaginal Contraceptive Film (VCF)

Contraceptive Vaccine

Ortho Evra Weekly Contraceptive Patch

NuvaRing Monthly Vaginal Ring

3. Research and Development

University of Kansas Conducts Research on the Male Pill

Clinical Trial of Contraceptive Spray

Oral Contraceptive Minimizes Premenstrual Syndrome Symptoms as per New Study

Indian Scientists in Process of Developing First Herbal Contraceptive Pill

Cause of Infertility - Not Associated with IUDs

Effectiveness of Norplant (Levonorgestrel implant)

Presence of Estrogen in OCs Offers Protection from Colorectal Cancer

Hormonal Contraceptive Usage & Risk Associated with Certain STDs

Use of Third Generation OCs Increases Risk of Blood Clots

High Risk of Deep Vein Thrombosis with Cyproterone-Containing OCs

4. Role of United Nations in Promoting use of Contraceptives

Female Condoms Reach New Heights with Aid from UNAIDS

Donor Support for Contraceptive Commodity

Table 15: Total Cost of Contraceptives and Condoms: 2000-2010P (includes corresponding Graph/Chart)

Unmet Need

Table 16: Donor Support by Region: 2004 (includes corresponding Graph/Chart)

Table 17: Contraceptive Donor Support for STI/HIV Prevention by Agency: 1997-2004

Donor Support by Contraceptive Method

Table 18: Donor Support by Contraceptive Method: 2000-2004 (includes corresponding Graph/Chart)

Table 19: Donor Support for Contraceptive Method by Agency: 2000-2004 (includes corresponding Graph/Chart)

Donor Support by Top Ten Countries

Table 20: Major Donor Support Recipient Countries: 2004 (includes corresponding Graph/Chart)

Table 21: Donor Support for Condoms and Other Contraceptive Commodities: 1997-2004 (includes corresponding Graph/Chart)

Donor Funding For Male Condoms

Table 22: Donor Funding For Male Condoms: 2000-2004 (includes corresponding Graph/Chart)

Table 23: Donor Funding For Male Condoms by Region: 2004 (includes corresponding Graph/Chart)

Table 24: Number of Male Condoms Supplied by Donors: Region-Wise Breakup for year 2004

Table 25: Donor Support for Condoms (1995-2004): Number of Condoms by Donor - USAID, UNFPA, BMZ/KfW, DFID, EU, DKT, PSI, IPPF, MSI, Netherlands, SIDA, and Japan (In Thousand Units) (includes corresponding Graph/Chart)

Table 26: Donor Funding for Condoms (1995-2004): Number of Condoms by Donor - USAID, UNFPA, BMZ/KfW, DFID, EU, DKT, PSI, IPPF, MSI, Netherlands, SIDA, and Japan (In US$ 000) (includes corresponding Graph/Chart)

Table 27: Total Number of Female Condoms in Private and Public Sectors: Region-wise Split from Years 1997 through 2004 (includes corresponding Graph/Chart)

Table 28: Percentage of Couples Using Condoms for Family Planning (2005) by Region

Use of Modern Contraceptives Grows in Developing Regions

Table 29: Estimated Numbers of Contraceptive Users in Developing Nations: 2000-2015 (includes corresponding Graph/Chart)

Table 30: Comparative Study of Modern Contraception Methods in Developing Regions (including India & China) and Developing Regions (excluding India & China) - Percentage of Married Women Using Oral Contraceptives, Female Sterilization, and Intrauterine Devices (IUDs): Recent Past Data for 2000 (includes corresponding Graph/Chart)

Difference in Usage of Oral Contraceptives in Developed and Developing World

Table 31: Oral Contraceptives Usage by Married and Sexually Active Unmarried Women (Aged 15-49 years) in Developed Regions including North America, Eastern Europe & Central Asia, and Australia & New Zealand: Recent Past Data for 2000

Table 32: Oral Contraceptives Usage by Married and Sexually Active Unmarried Women (Aged 15-49 years) in Developing Regions including Asia, Near East & North Africa, Sub-Saharan Africa, Pacific Rim, and Latin America & Caribbean: Recent Past Data for 2000 (includes corresponding Graph/Chart)

Prevalence of Contraceptive Methods

Table 33: Increase in Contraceptive Usage by 2005 - Percentage Share Growth by Asia, Latin America and Africa (includes corresponding Graph/Chart)

Table 34: Worldwide Contraceptives Market: Estimated Number of Users (2015 & 2025) - Asia, Latin America and Africa (includes corresponding Graph/Chart)

Table 35: Worldwide Contraceptive Market: Prevalence Amongst Women (2000-2025) - Percentage Share by Asia, Latin America and Africa (includes corresponding Graph/Chart)

United Nations Population Fund (UNFPA)

UNFPA Gets Aid from Britain to Help Developing World

Rise in Cost of Providing Contraceptives

Future Trends Worldwide

5. New Product Introductions/Innovations

FHI and HLL Launch Aastha Condom

NATCO Launches World-Class Oral Contraceptive

Bayer Plans Launch of Mirena in Japan

Barr Pharmaceuticals Unveils Generic Version of SEASONALE®

PSI Launches Trust Condoms in Uganda

Tanzania Marketing and Communication Launches a New Brand of Condoms

German Group to Launch Innovative Spray-on Condom

Hindustan Latex Unveils First-Ever Female Condom in Indian Market

Church & Dwight’s Trojan Launches Unique Twister Condom

Berlex Inc. Introduces New Oral Contraceptive in the United States

Hindustan Latex Launches the Moods ‘Get Closer Pack’

Warner Introduces First-of-its-Kind Chewable Oral Contraceptive

Warner Announces FDA Approval for Loestrin® 24 Fe Contraceptive Pill

Huge Brand Unveils "Huge" Brand of Condoms

Private Media Group and Zemtex Introduces Private Brand of Condoms

Hindustan Latex Launches New Varieties of ‘Moods’ Condom

Organon Introduces Marvelon 21, Oral Contraceptive in Japan

GlaxoSmithKline India Unveils Elogen, a Low Dose Contraception Pill

USAID’s T-MARC Launches Two Female Contraceptives in Tanzania

SMC Plans to Introduce First Implantable Male Contraceptive

Zimbabwe in Alliance with Indian Company Launches New Oral Contraceptive Products

Global Protection Adds “ONE Condoms(C)” to its Product Line

Hubei Pharmaceutical Launches a New Contraceptive

Intellx Inc Announces Expansion of VA Women's Condom

DKT Ethiopia Re-Launches Sensation Condoms

Transdermal Contraceptive Spray under Clinical Testing by Population Council and Acrux

Prasco Launches Cesia, a New Generic Oral Contraceptive

FHC Launches Female Condom in India

FHC Files Patent for Second-Generation Version of the Female Condom

FHCO Enters into Agreement with USAID

Barr Laboratories Launches Extended-Cycle Oral Contraceptive, Seasonale

Central Drug Research Institute to Launch Consap

Johnson & Johnson Introduces Evra in UK

Allendale Pharmaceuticals Relaunches Today Sponge

New V-Amour Women's Condom Introduced in Germany

Durex Introduces Intense Sensation Condoms

Durex Launches Performax Condoms

Ortho-McNeil Introduces Ortho Evra

Pasante Healthcare Launches Pasante Condoms Range

Hindustan Latex Debuts New Lubricated Condoms

Durex Launches 'Easy-on' line of Condoms

Rayson Healthcare Introduces new Condom Brand

Ansell healthcare Unveils Contempo Lubricated Latex Condoms

Church & Dwight Launches Trojan Her Pleasure Premium Latex Condoms

Pharmacia Introduces Depo-Provera contraceptive in 1ml vials

Organon Debuts NuvaRing contraceptive

Organon Laboratories Introduces Cerazette

Barr Rolls Out Lessina Contraceptive Tablets

Schering Introduces Yasmin Across the US and Europe

Condomania Introduces New Packaging

Condomania Launches Newly Designed, InSpiral Condoms

Condomania Introduces Pleasure Plus Condoms

Durex Consumer Launches Two New Varieties

Church & Dwight’s Consumer Products Division Launches Two Innovative Products

Ansell Launches LifeStyles Luscious Flavors Condoms

Trojan Introduces Extended Pleasure Premium Latex Condoms

JK Ansell Launches New Sub-Brand, Kamasutra Sport

JK Ansell Launches Kamasutra Xtra Pleasure Condoms

TTK-LIG Launches Pink Version of Kohinoor Luxury Condoms

Condomi Launches Vegan-Friendly Condoms in UK

Berlex Launches Mirena in US

Schering Introduces Levonelle in UK

Organon Launches Cyclessa

Barr Laboratories Launches New Generic Oral Contraceptives in the US

Duramed Introduces New Oral Contraceptives in the US

American Pharmaceutical Partners Launch New Product

Swiss Health Launches Vitex Agnus Castus

Sun Pharmaceutical Launches Puregest Progesterone Capsules

6. Recent Industry Activity

Organon Licenses Spray Technology from Acrux

BioSante Initiates Phase II Trials of Oral Contraceptives

YAZ® Receives FDA Approval for New Indication

Paladin Labs Receives Approval to Market SEASONALE®

ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Receives Two FDA Approvals (USA)

Conceptus Receives FDA Approval for Third-Generation Essure ® Procedure

Wyeth Receives FDA Approval for Lybrel ™

NuvaRing® Completes European Authorization in 13 Countries

HLL Expands Promotion of Female Condom

ChrysCapital Gains Minority Stake in Mankind Pharma

7 Chemicals Inks Deal with Ferring Pharmaceuticals

Synova Acquires Allendale Pharmaceuticals and Global Rights to Today Sponge

Ansell Pockets Blowtex

Bayer Merges with Berlex to Establish Bayer HealthCare Pharmaceuticals

UNFPA Releases Pacific-Design Condoms

Wyeth Completes Acquisition of Wyeth K.K. Japan

Conceptus, Inc. to Acquire Conceptus SAS

Warner Chilcott Company Enters into a Supply Agreement with Watson Pharma

SSL International Fully Acquires Qingdao London Durex Co Ltd

Bayer HealthCare Takes Over Marketing/Distribution Network of Pharmonyx Ltd

USFDA Grants OTC Status Plan B (R)

Ethiopia Enters into Agreement with UNFPA and UNICEF

YAZ® Receives FDA Approval

FHC Receives USAID Orders

FHC Signs MoU with Hindustan Latex Ltd

IMPLANON™ Receives US FDA Approval

Watson Pharmaceuticals Receives Approval for Generic Version of Seasonale®

Watson Pharmaceuticals Receives Approval for Generic Version of Levlite®

Ansell Acquires Stake in Wuhan Jissbon Sanitary Products

Ansell Acquires Unimil of Poland

Conceptus Joins Hands with Gyrus and Olympus on Hysteroscopy

Watson Acquires Andrx

Bayer Acquires Schering AG

Duramed Acquires FEI

Schering and Organon to Terminate Research Collaboration

ACR Extends Existing Agreement with Population Council

Antares Inks Contraceptive Development Agreement with Population Council

FHC to Enhance Manufacturing Capacity of FC2 Female Condom

Medevice 3S Establishes Condom Manufacturing Facility

SSL International to Acquire Additional 50% Stake in Qingdao London Durex in China

Female Health Company Signs an Agreement with Fuji Latex

Female Health Company Obtains Order for the Supply of Female Condoms from India

Conceptus Receives Cigna’s Approval for Reimbursement of Essure Procedure

Barr Pharmaceuticals Obtains FDA Approval for Duramed's SEASONIQUE™ Oral Contraceptive

Schering AG Receives European Approval for Yasminelle® Contraceptives

AMMD Takes Over Ovion

Duramed Pharmaceuticals Enters into a License and Distribution agreement with Paladin

Female Health Company Bags Brazilian Order for FC Female Condoms

Female Health Company Enters into an Agreement with the World YWCA for Distribution of FC2 Female Condoms™

Akzo Nobels Receives Development and Marketing Rights for EMM 310066 Contraceptive

Conceptus and Gynecare Terminates their Sole Co-Promotion Agreement

FTC Sues Warner Chilcott and Barr

Acrux Concludes Phase I Clinical Trial for Spray on Contraceptive

Vulkan and CPR to Set Up a Joint Venture for the Production of Condoms

Warner Chilcott Acquired by Investment Group

Brazil Based Sao Roque Condoms Plant to Expand Production Capacity

Berlex Receives Approval for Yasmin Tablets in Canada

Mochida Pharmaceutical to Exclusively Distribute Ortho 777-21 and OrthoM-21 in Japan

Barr Laboratories Obtains Approval for Demulen Tablet

Clinical Trials on Male Contraceptive

FHC Receives Distribution Order from South Africa

China to Purchase Contraceptives Worth US$ 45.7 Million

Female Health Company Signs Agreement with BZP

Duramed Acquires Exclusive Rights to Nordette® from King Pharmaceuticals

Berlex Laboratories Inc. Renamed Berlex, Inc

Duramed Pharmaceuticals Acquire Rights to Loestrin (R) from Galen

Galen Receives Option to License Barr’s Generic Ovcon (R) 35

Barr Acquires Shares of Women’s Capital Corporation

Galen Signs a Licensing Agreement with Barr

Galen Acquires Pfizer Manufacturing Facility

Polar Pharma to Expand Production Capacity and Re-launch ‘Adam’ Condoms

Prasco Signs an Agreement with Organon

Pfizer Acquires Pharmacia Corp

Teva and Andrx in Collaborative Arrangement

Barr Laboratories Acquires Marketing Rights

Barr Laboratories Signs Mutual Agreement with Galen

Pfizer Sells Women's Health Care Products to Galen

FDA Approves Ovcon 35

Barr Obtains FDA Approval for ANDA

FHC Enters into an Agreement with HLL

Watson Signs an Agreement with OMJ

Ortho-McNeil Receives Approval for ORTHO TRI- CYCLEN LO

American Home Products Restructures and Changes Name to Wyeth Corporation

Ansell Promotes the Fun Factor Embarks on ‘It Feels Right’ Campaign

FDA’s Approval for Barr's generic Ortho-Cyclen Tablet

Warner-Chilcott Acquires Two Healthcare Products from Bristol-Myers

Ansell Acquires Johnson & Johnson’s Canadian Condom Business

SSL Acquires Joint Venture Partner in Seton Scholl Japan Ltd

CSI Acquires Plant in North Las Vegas for Condom Production

Barr Laboratories Merges with Duramed Pharmaceuticals

Condomi Enters into a Strategic Joint Venture

Condomi in Alliance with MCM

FHC Enters into Supply Contract in Brazil

FHC Secures Contract from UNFPA

FHC Receives Contract from South African Health Department

Carter Wallace Divests Consumer Brands to Armkel

SSL Restructures Business Operations

FHC Renames Female Condom

US Branch of SSL International Group Renamed

7. Focus on Select Players

Ansell Limited (Australia)

Barr Pharmaceuticals, Inc. (US)

Church & Dwight Co Inc (US)

Conceptus Inc (US)

Condomi Health International GmbH (Germany)

Female Health Company (US)

Fuji Latex Co (Japan)

Johnson & Johnson (US)

Ortho-McNeil Pharmaceutical Inc (US)

Okamoto Industries Inc (Japan)

Schering-Plough Corporation (US)

Organon USA Inc (US)

Bayer Schering Pharma AG (Germany)

SSL International PLC (UK)

Warner Chilcott PLC (US)

Wyeth Corporation (US)

8. Global Market Perspective

Table 36: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 37: World Long-term Projections for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 38: World 10-Year Perspective for Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2007 & 2010 (includes corresponding Graph/Chart)

Table 39: World Recent Past, Current & Future Analysis for Oral Contraceptives by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 40: World Long-term Projections for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 41: World 10-Year Perspective for Oral Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2007 & 2010 (includes corresponding Graph/Chart)

Table 42: World Recent Past, Current & Future Analysis for Condoms by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 43: World Long-term Projections for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 44: World 10-Year Perspective for Condoms by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2007 & 2010 (includes corresponding Graph/Chart)

Table 45: World Recent Past, Current & Future Analysis for Implants/Injections by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 46: World Long-term Projections for Implants/Injections by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 47: World 10-Year Perspective for Implants/Injections by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2007 & 2010 (includes corresponding Graph/Chart)

Table 48: World Recent Past, Current & Future Analysis for Other Contraceptives by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 49: World Long-term Projections for Other Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 50: World 10-Year Perspective for Other Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2000, 2007 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Outlook

Restraints

Major Market Trends

Changing Consumer Demographics

Relentless Promotional Programs Drive Home the Point

Use of Intimacy Products on the Rise

Table 51: US Contraceptives Ad Spend (2005): Percentage Breakdown by Dollars Spent on Radio, Out of Home Advertising, Television, Magazine, and Newspaper (includes corresponding Graph/Chart)

Generics Ransack the Branded Market

Condoms - A ‘Fun, Inviting and Pleasurable’ Way to Healthy Life and Lifestyle

Trojan Dominates the Condoms Market in the US

Market Share Statistics

Table 52: US Market for Male Contraceptives: Percentage Breakdown of Retail Dollar Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)

Table 53: US Market for Male Contraceptives: Breakdown of Retail Unit Sales of Key Players for the Year Ended January 2007 (In 000 Units) (includes corresponding Graph/Chart)

Table 54: US Market for Female Contraceptives: Percentage Breakdown of Retail Dollar Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)

Table 55: US Market for Female Contraceptives: Percentage Breakdown of Retail Unit Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)

Table 56: US Market for Female Contraceptives: Percentage Breakdown of Dollar Sales of Leading Brands for the Year Ended March 2005 (includes corresponding Graph/Chart)

Noticeable Shift in Retail Marketing Techniques

Rising Use of Condoms Amongst Teenagers

Changing Attitudes and Perceptions Drive Market Sales

Pill Continues to be One of the Most Popular Forms of Contraception

Table 57: Leading Methods of Contraception in the US : Percentage Breakdown by Method of Contraception for Oral Contraceptives, Condoms, Female Sterilization, Male Sterilization, Withdrawal, Injectables, Rhythm, Intrauterine Devices, Other(s), and No Method Followed (includes corresponding Graph/Chart)

Oral Contraceptives and its Shades of Grey

Marketing Efforts Aimed at Influencing Female College Students

Condoms Continuing Canter

Table 58: US Condoms Market (Recent Past Data for 2003): Consumer Purchasing Patterns for Condoms at All Retail Outlets, Drug Stores, Supermarkets, Supercenters, and Discount Stores (includes corresponding Graph/Chart)

Drug Stores Remain the Choice for Contraceptive Needs

Trade Class Statistics

Table 59: Leading Male Contraceptives Brands in the US (2005) - Percentage Share Breakdown by Sales Revenues through Drug Stores - Trojan, Trojan Enz, Trojan Magnum, LifeStyles, Durex Extra Sensitive, Trojan Her Pleasure, Kling-Tite Naturalamb, Durex and *Others (includes corresponding Graph/Chart)

Table 60: Leading Male Contraceptive Brands in the US (2005) - Percentage Share Breakdown by Volume Sales through Drug Stores - Trojan, Trojan Enz, Trojan Magnum, Durex Extra Sensitive, LifeStyles, Trojan Her Pleasure, Durex, Trojan Supra and *Others (includes corresponding Graph/Chart)

Table 61: Leading Brands in the US Condoms Market (2004): Percentage Share Breakdown by Trade Class (Supermarkets, Drug Stores, and Discount Stores (Excluding Wal-Mart)) Sales for Trojan, Trojan Enz, Lifestyles, Durex Extra Sensitive, Trojan Magnum, Trojan Ultra Pleasure, Trojan Her Pleasure, Kling Tite Naturalamb, Trojan Extended Pleasure, Lifestyles Ultra Sensitive, and Others (includes corresponding Graph/Chart)

Table 62: Leading Drug Store Brands in the US Condoms Market (2003): Percentage Share Breakdown for Trojan, Trojan Enz, LifeStyles, Trojan Magnum, Durex Extra Sensitive, Kling Tite Natural Lamb, Trojan Her Pleasure, Trojan Ultra Pleasure, Trojan Extended Pleasure, Durex, and Others (includes corresponding Graph/Chart)

Table 63: Leading Supermarket Brands in the US Condoms Market (Recent Past Data for 2001-2003): Percentage Share Breakdown by Trojan, Trojan-Enz, Lifestyles, Sheik Super, Class-Act, Sheik-Classic, Naturalamb and Others (includes corresponding Graph/Chart)

Table 64: Leading Condom Brands in the US Market (Recent Past Data for 2003): Percentage Breakdown by Trojan, Trojan Enz, Lifestyles, Durex Extra Sensitive, Trojan Ultra Pleasure, Kling Tite Natural lamb, Trojan Magnum, Durex Ultimate Feeling, Trojan Supra and Durex High Sensation (includes corresponding Graph/Chart)

Table 65: Sales of Condoms Through Leading Distribution Channels in the US (2005) -Drug Stores, Discount Stores and Supermarkets (includes corresponding Graph/Chart)

Table 66: Distribution Channel Percentage Share - US Male Contraceptives (Recent Past Data for 2003 & 2002) - by Chain Drug Stores, Discount Stores, Food/Drug Combination Stores, Independent Drug Stores and Supermarkets (includes corresponding Graph/Chart)

Table 67: US Contraceptives Market: Average Price per Unit of Male and Female Contraceptives for he Year 2006 (In US $)

Table 68: Total Contraceptives Market in the US (2005) - Percentage Share Breakdown by Trade Class (Supermarkets, Drug Stores, and Discount Stores (Excluding Wal-Mart)) Value Sales for Male Contraceptives and Female Contraceptives

Table 69: US Condoms Market: Percentage Breakdown of Dollar Sales by Product Type for the Year Ended January 2006 (includes corresponding Graph/Chart)

Oral Contraceptives - Unanimously the Choice of American Women

Table 70: Contraceptive Features Preferred by Women in US (includes corresponding Graph/Chart)

Table 71: US Market for Oral Contraceptive Drugs (2004): Percentage Breakdown of Dollar Sales of Leading Brands (includes corresponding Graph/Chart)

Table 72: US Market for Oral Contraceptive Drugs (2004): Breakdown of Leading Brands by Total Number of Prescriptions (TRx) (In Million) (includes corresponding Graph/Chart)

Table 73: US Oral Contraceptive Market: Percentage Breakdown of Dollar Sales of Branded Oral Contraceptives and Branded-Generic Oral Contraceptives for the Years 2002 & 2004

Table 74: US Market for New Prescription (NRx) Oral Contraceptive (Estrogen/Progestogen-based) Drugs (2006): Percentage Market Share Breakdown of Leading Players (includes corresponding Graph/Chart)

Table 75: US Market for Prescription (Rx) Oral Contraceptives: Percentage Market Share Breakdown of Leading Players for the Years 2007E and 2010(P) (includes corresponding Graph/Chart)

Table 76: US Prescription Contraceptives Market: Percentage Market Share Breakdown for Select Product Categories for the Years 2007E & 2010P (includes corresponding Graph/Chart)

Table 77: US Market for Prescription Extended Cycle Oral Contraceptives: Percentage Market Share Breakdown for Leading Brands for the Years 2007E & 2010P (includes corresponding Graph/Chart)

Export & Import Statistics

Table 78: US Exports of Chemical Contraceptive Preparations (Based on Hormones or Spermicides): Breakdown of Export Value by Select Destination Countries for the Year 2006 (In US $ Thousand) (includes corresponding Graph/Chart)

Table 79: US Imports of Chemical Contraceptive Preparations (Based on Hormones or Spermicides): Breakdown of Import Value by Select Countries of Origin for the Year 2006(In US $ Thousand) (includes corresponding Graph/Chart)

Table 80: US Exports of Sheath Contraceptives made of Vulcanized Rubber (other than hard rubber) : Breakdown of Export Value by Select Destination Countries for the Year 2006(In US $ Thousand) (includes corresponding Graph/Chart)

Table 81: US Imports of Sheath Contraceptives made of Vulcanized Rubber (other than hard rubber): Breakdown of Import Value by Select Countries of Origin for the Year 2006(In US $ Thousand) (includes corresponding Graph/Chart)

Table 82: Contraceptives Market in the US: Leading Hormonal Contraceptives (Recent Past Data for 2002) - Percentage Share by Developer/Marketer: J&J, Wyeth Corp, Schering AG, Akzo Nobel’s Organon, Pharmacia and Pfizer (includes corresponding Graph/Chart)

Health Facts

Rising Use of Oral Contraceptives

Abortion Control Drugs & Methods

Medical Abortion

a. Mifepristone - A Medical Breakthrough

b. Methotrexate

Expanding the Use & Availability of EC Drugs

Pharmacies Sell ECPs

Demographics

Facts and Figures

Sales of Contraceptives (Male & Female) - Family Planning Category

Insurance Coverage for Contraceptives Still in Contest

Key Players

Product Launches

Strategic Corporate Developments

B. Market Analytics

Table 83: US Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 84: US Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 85: US 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

2. Canada

A. Market Analysis

Scenario

Efforts on Way to Launch Male Contraceptive Injection

Outlook

Condoms Market

Immucon Obtains US Patent for Male Contraceptive Technology

Exports & Import Statistics

Table 86: Canadian Exports of Chemical Contraceptive Preparations (Based on Hormones or Spermicides): Percentage Breakdown of Export Value by Select Destination Countries for the Year 2005 (includes corresponding Graph/Chart)

Table 87: Canadian Imports of Chemical Contraceptive Preparations (Based on Hormones or Spermicides): Percentage Breakdown of Import Value by Select Countries of Origin for the Year 2005 (includes corresponding Graph/Chart)

Table 88: Canadian Exports of Sheath Contraceptives made of Vulcanized Rubber (other than hard rubber): Percentage Breakdown of Export Value by Select Destination Countries for the Year 2005 (includes corresponding Graph/Chart)

Table 89: Canadian Imports of Sheath Contraceptives made of Vulcanized Rubber (other than hard rubber): Percentage Breakdown of Import Value by Select Countries of Origin for the Year 2005 (includes corresponding Graph/Chart)

Strategic Corporate Developments

B. Market Analytics

Table 90: Canadian Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 91: Canada Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 92: Canadian 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Outlook

Market for Oral Contraceptives Yet to Take Off

Innovation Expected to Drive Sales

Major Issues and Trends

Domestic Products Dominate the Market

Health Care Institutions Remain Main Distribution Channels

Table 93: Japanese Contraceptives Market: Leading Players - Systemic Hormonal Contraceptives (Recent Past Data for 2002) - Percentage Share Breakdown - J&J, Wyeth Corp, Schering AG, Akzo Nobel, Pharmacia, Pfizer, Watson, Duramed, Galen, Gruenenthal and Others (includes corresponding Graph/Chart)

Market Issues

Compulsory Labeling of Contraceptives

Late Approval for Use of OCs in Japan

Factors Hindering Widespread Use of OCs

Condoms Market

Table 94: Leading Players in the Japanese Condoms Market (2001-2004)-Percentage Share Breakdown by Shipments - Okamoto Industries, Sagami Rubber Industries & Fuji Latex Co (includes corresponding Graph/Chart)

Key Players

Product Launches

Strategic Corporate Developments

B. Market Analytics

Table 95: Japanese Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 96: Japanese Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 97: Japanese 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4. Europe

A. Market Analysis

Outlook

Condoms Market

Strategic Corporate Development

B. Market Analytics

Table 98: European Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 99: European Long-term Projections for Contraceptives by Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 100: European 10-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2000, 2007 & 2010 (includes corresponding Graph/Chart)

Table 101: European Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 102: European Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 103: European 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4a. France

A. Market Analysis

Outlook

Condoms Market

Strategic Corporate Development

B. Market Analytics

Table 104: French Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 105: French Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 106: French 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4b. Germany

A. Market Analysis

Outlook

German Women Record Highest Usage Rate of Contraceptive Pill

Condoms Market

Table 107: Leading Players in the German Condoms Market (2005) - Percentage Share Breakdown by Sales Revenues - Sico, Vizit and Others (includes corresponding Graph/Chart)

Key Players

Strategic Corporate Developments

B. Market Analytics

Table 108: German Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 109: German Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 110: German 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4c. Italy

A. Market Analysis

Outlook

B. Market Analytics

Table 111: Italian Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 112: Italian Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 113: Italian 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4d. The United Kingdom

A. Market Analysis

Outlook

Overview

Changing Societal Trends

Innovations: Need of the Hour

Table 114: Contraception Market in the United Kingdom: Percentage of Women Aged 16-49 Years Using Select Methods of Contraception As of the Year 2005-06 (includes corresponding Graph/Chart)

Availability of Contraceptives

Contraceptive Injections

Emergency Contraception (EC)

Barrier Contraceptives

Major Trends and Issues

Hormone Based Products Overtake Barrier Products

Condoms Still Find Immense Favor in Britain

Value of Condoms Declines Even as Volume Sales Increases

Table 115: Leading Players in the UK Condoms Market (2005) - Percentage Share Breakdown by Sales Revenues Durex, Contex and Others (includes corresponding Graph/Chart)

Role of Pharmacies in Improving Availability of Condoms and EC Drugs

Regulatory Environment

CEN Standards

Advertising and Promotion

Hormone Based Contraceptives Restricted by Legislation

Key Player

Strategic Corporate Developments

B. Market Analytics

Table 116: UK Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 117: UK Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 118: UK 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4e. Spain

A. Market Analysis

Outlook

B. Market Analytics

Table 119: Spanish Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 120: Spanish Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 121: Spanish 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4f. Russia

A. Market Analysis

Outlook

Table 122: Popular Condom Brands in Russia (Recent Past Data for 2002) (includes corresponding Graph/Chart)

Strategic Corporate Development

B. Market Analytics

Table 123: Russian Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

TABLE 124: Russian Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 125: Russian 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

4g. Rest of Europe

A. Market Analysis

Outlook

Czech Republic

Denmark

Portugal

Table 126: Contraceptives Market in Portugal: Usage of Contraceptive Methods- Percentage Share by Condoms, OCs/Pill, Combination Method, Withdrawal and Calendar Method (includes corresponding Graph/Chart)

Poland

Other Countries

Strategic Corporate Developments

B. Market Analytics

Table 127: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 128: Rest of Europe Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 129: Rest of Europe 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2005 &2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Outlook

Market Primer

Greater Need for Contraception Awareness Among Adolescents

Table 130: Contraceptives Market in Asia-Pacific: Married Adolescent Women Using Reversible Female Methods (Recent Past Data for 2003)- Percentage Share for Bangladesh, India, Pakistan and Thailand (includes corresponding Graph/Chart)

Table 131: Contraceptives Market in Asia-Pacific: Married Adolescent Women Knowledgeable about Condoms (Recent Past Data for 2003)- Percentage Share for Pakistan, Sri Lanka, Bangladesh, Indonesia, Philippines and Thailand (includes corresponding Graph/Chart)

Oral Contraceptives Hold Potential for Growth

Table 132: Oral Contraceptives Usage by Married Women (Aged 15-49 years) in East Asia (excluding China), South Central Asia (excluding India), Southeast Asia, India, China, and Asia: Recent Past Data for 2000 (includes corresponding Graph/Chart)

Condoms Shortage Raise Fears of More HIV/AIDS Infections

Bangladesh

Indonesia

Subsidized Condoms Clearly Dominate Other Products

Contraceptives Market in Indonesia: Condom Manufacturers & Respective Brands (Recent Past Data for 2002) - PT Sawah Besar Farma, PT Mitra Rajawali Banjaran, PT

Anugerah Pharmindo and PT Vonix Latexindo

Rise in Contraceptive Use and Decline in Fertility Characterizes Indonesia

Pakistan

The Philippines

Table 133: Use of Modern Contraceptive Methods in Philippines: Percentage Use of Select Contraceptive Methods Among Women in Union for the Years 2003, 2008(E), and 2011(P) (includes corresponding Graph/Chart)

Table 134: Market for Injectable Contraceptives in Philippines (2004): Percentage Breakdown of Dollar and Unit Sales of Leading Players, and Their Brands (includes corresponding Graph/Chart)

Table 135: Market for Oral Contraceptive Pills in Philippines (2004): Percentage Market Share Breakdown of Leading Players, and their Brands (includes corresponding Graph/Chart)

Table 136: Average Prices of Popular Oral & Injectable Contraceptive Brands in Philippines As of the Year 2004 (In Philippine Peso) (includes corresponding Graph/Chart)

Vietnam

China

Overview

Contraceptive Requirements

14-Year Ban on Condom Advertising Finally Lifted

Condoms Witness Increasing Demand

India

Overview

Major Intra-Uterine Devices (IUD) and Injectable Contraceptive Brands Sold In India (2003)

Rise in Population Fuels Growth

Family Planning, Need to Address Requirements

Table 137: Percentage Prevalence of Select Contraceptive Methods in India As of the Year 2003 (includes corresponding Graph/Chart)

Table 138: Indian Contraceptives Market: Contraceptives Use (Recent Past Data for 2003) - Percentage Shares Himachal Pradesh, West Bengal, Punjab, Uttar Pradesh, Bihar and Meghalaya (includes corresponding Graph/Chart)

Oral Contraceptives

Indians Women Fairly Open to the Concept of OCs

Free Distribution Scheme

Global Brands Still Alien to Indians

Commercial Brands of Oral Contraceptives Pills Available in India (2003)

Emergency Contraceptives -A Sunrise Segment

Emergency Contraception Pills Sold In India (2003) - A Peek Into Major Brands by Distribution Channels

Social Marketing Scheme (SMS)

Goli Ke Hamjoli Campaign

Playing a Significant Role

Contraceptives Distributed by Marketing Companies & NGOs Under Social Marketing Schemes

Condoms

Overview

Table 139: Indian Condom Manufacturers & Production Capacities (Recent Past Data for 2003)- Hindustan Latex Ltd, TTK LIG, Polar Latex Ltd, JK Ansell and TTK - Biomed (includes corresponding Graph/Chart)

Supply

Market Segments

Leading Condom Brands and Companies (Recent Past Data for 2002) -Subsidized & Non-Subsidized Categories

Table 140: Leading Condom Brands in India (Recent Past Data for 2003)- Percentage Share for Kohinoor Pink, Kamasutra and Moods (includes corresponding Graph/Chart)

Key Player III-109 Rest of Asia-Pacific

Australia

Ansell Limited - A Key Player

Sri Lanka

Annual Demand for Contraceptives in Sri Lanka: Recent Past Data for 2002

Bangladesh

Pakistan

Factors Obstructing Improvement of Reproductive Health Status

Availability of Contraceptive Products/Devices

Table 141: Contraceptives Requirement in Pakistan for Different Organizations: Recent Past Data for 2002-2003

Thailand

Sex Education - Need of the Hour

Table 142: Leading Players in the Thai Condomsc Market (2005) - Percentage Share Breakdown by Sales Revenues - Durex, and Others (includes corresponding Graph/Chart)

Table 143: Leading Methods of Birth Control in the Thai Contraceptives Market (2005) - Percentage Share Breakdown - Sterilization, Birth Control Pills, Intra-Uterine Devices and Condoms (includes corresponding Graph/Chart)

Vietnam

Product Launches

Strategic Corporate Developments

B. Market Analytics

Table 144: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 145: Asia-Pacific Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 146: Asia-Pacific 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

6. Latin America

A. Market Analysis

Outlook

Popular Contraceptives in Latin America and the Caribbean

Table 147: Oral Contraceptives Usage by Married and Sexually Active Unmarried Women (Aged 16-50 years) in the Caribbean, Central America, South America, and Latin America: Recent Past Data for 2000

Argentina

Brazil

Contraceptives Market Grows Larger by the Day

Role of Condom Social Marketing (CSM)

New Contraceptive Companies Face Tough Competition

Players

Table 148: Leading Players in the Brazilian Hormonal Contraceptives Market (Recent Past Data for 2003) - Percentage Breakdown by Value and Volume sales for Schering do Brasil, Organon and Wyeth (includes corresponding Graph/Chart)

Colombia

Ecuador

Guatemala

Mexico

Strategic Corporate Developments

B. Market Analytics

Table 149: Latin American Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 150: Latin America Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 151: Latin American 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

7. Rest of World

A. Market Analysis

Outlook

Middle East

Socio-Cultural Factors Influencing Use of Condoms

Oral Contraceptives Usage Patterns in Near East and Africa

Table 152: Oral Contraceptives* Usage by Married and Sexually Active Unmarried Women (Aged15-49 years) in Near East, North Africa, Central Africa, East Africa, South Africa and West Africa: Recent Past Data for 2000

Jordan

Table 153: Health Scenario in Syria & Jordan - Recent Past Data for 2002 (includes corresponding Graph/Chart)

Jamaica

Post Offices Playing Key Role in Improving Condom Accessibility

Africa

Female Condoms Gain Ground in South Africa

Uganda

Condoms - A Case of Anti-AIDS Success

Kenya

Zimbabwe

Churches in Dilemma Over Condom Use in Zimbabwe

Other Countries

Product Launches

Strategic Corporate Developments

B. Market Analytics

Table 154: Rest of World Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 155: Rest of World Long-term Projections for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 156: Rest of World 10-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2000, 2007 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 165 (including Divisions/Subsidiaries -191 )

Canada 3

Japan 3

Europe 37

France 3

Germany 11

The United Kingdom 6

Italy 1

Spain 1

Rest of Europe 15

Asia-Pacific (Excluding Japan) 67

Middle East 2

Africa 2

Latin America 34

Abstract

This report analyzes the worldwide markets for Contraceptives in Millions of US$. The specific product segments analyzed are Oral Contraceptives, Condoms, Implants/ Injections, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 165 companies including many key and niche players worldwide such as Ansell Limited, Barr Pharmaceuticals, Inc., Church & Dwight Co. Inc., Conceptus, Inc., Condomi Health International GmbH, Female Health Company, Fuji Latex Co., Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc, Okamoto Industries, Inc., Schering-Plough Corporation, Organon USA Inc, Bayer Schering Pharma AG, SSL International PLC, Warner Chilcott PLC, and Wyeth Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.